Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation
Which stocks are undervalued right now? Check free
Discover now →
Manolete Partners Plc (MANOF) fair value: what the stock is really worth
As of Sep 25, 2026: fair value of Manolete Partners Plc $0.69, price $0.49, upside +39.6%, quality 63 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Fair value above price? Yes
- Good quality? Yes
- Add to watchlist
MP
Broad data
Sep 24, 2026
Broad data
Sep 24, 2026
Manolete Partners Plc
MANOF · USUndervaluedThe stock appears undervalued with acceptable quality.
✓Fair value $0.6900 · Undervalued (+39.6%)
✓Quality 63/100
!Mixed Growth (revenue 5y +10.3 %/yr)
!Thin margins · 2.2% net margin (TTM)
✓Low debt · generates free cash flow
!Narrow moat 22/100
What runs behind every stock
26
valuation models
8 families, DCF to NCAV
37
quality factors
margins, balance sheet, cashflow, debt
6
AI factors
moat, what no ratio measures
2,000+
data points
verified, per stock, median
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $0.4800 – $3.00 · fair‑value band $0.4800 – $0.8900 · the $0.4942 price screens below the $0.6900 fair value. Dashed = 300-day average. As of Sep 24, 2026.
Company profile
Manolete Partners Plc operates as an insolvency litigation financing company in the United Kingdom. It is involved in the acquisition and funding of insolvency litigation cases. The company was founded in 2009 and is headquartered in London, the United Kingdom.
Stock analysis
Manolete Partners Plc (MANOF) currently trades at $0.4942, while our model-based Fair Value estimate is $0.6900, implying the stock looks roughly 28.4% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of $1.40 per share, and 17 of the 23 models we run sit above the $0.4942 price.
Bear case: the Economic Profit group reads lowest at $0.4700, and 6 of the 23 models stay below the price. Evidence for this calculation is high.
Scenario range: $0.4800 (bear) to $0.8900 (bull), the price of $0.4942 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 63/100 (solid quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Manolete Partners Plc reported revenue of £30.5M in FY2025 versus £27.8M in FY2021, a compound +2.3%/yr. Reported net income was £893K in FY2025, compounding −37.1%/yr from FY2021.
Key figures
Market cap $22.0M · P/E ratio 24.7 · P/S ratio 0.72 · EPS (TTM) $0.0200 · Net margin 2.9% · Return on equity 1.6% · Return on assets (EBIT) 4.6% · Operating margin 0.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 60% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at 3% fair-value upside, at 40%, MANOF screens cheaper than that median.
Fair Value models
Bear $0.4800
Fair Value $0.6900
Bull $0.8900
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 12 months old). Earnings retained since then ($0.0200 per share) are deliberately not added.
Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.
Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
EPV
$0.3600
$0.4700
$0.5600
74
FCF DCF
$0.8000
$1.64
$3.79
73
Growth DCF
$0.7600
$1.83
$3.66
73
All 23 models by family
DCF Models
FCF DCF
$0.8000
$1.64
$3.79
73
5Y Revenue Exit
$0.5900
$1.40
$2.65
68
5Y EBITDA Exit
$0.5900
$1.40
$2.56
71
5Y P/E Exit
$0.2900
$0.7500
$1.30
67
10Y Revenue Exit
$0.6200
$1.47
$2.75
63
10Y EBITDA Exit
$0.6500
$1.47
$2.87
64
10Y P/E Exit
$0.4500
$0.9500
$1.72
61
Earnings-Based
Graham-Dodd
$0.1800
$1.16
$1.63
63
Lynch FV
$0.3400
$0.4800
$0.6200
61
PEG = 1.0
$0.3400
$0.4800
$0.6200
57
EPV
$0.3600
$0.4700
$0.5600
74
Multiples
P/E Multiple
$0.4300
$0.5700
$0.7100
63
P/S Multiple
$0.3400
$0.4600
$0.5700
58
P/B Multiple
$0.3400
$0.4600
$0.5700
55
EV/EBIT
$0.8100
$1.19
$1.57
65
EV/EBITDA
$0.5400
$0.8300
$1.12
66
EV/Revenue
$0.4800
$0.8300
$1.18
52
Asset-Based
NCAV (Graham)
$0.6300
$0.8400
$1.25
54
Growth DCF
Growth DCF
$0.7600
$1.83
$3.66
73
Rev-Margin DCF
$0.5900
$1.40
$2.55
69
Economic Profit
Residual Income
$0.8700
$0.8200
$0.8200
71
ROIC Compounder
$0.3600
$0.4700
$0.5600
72
Growth Earnings
Growth-Adj P/E
$0.4800
$0.6800
$0.8900
67
Notify me when MANOF reaches fair value
Put MANOF on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Quality Score breakdown
Overall quality
63/100
Of which business quality 63 · Market factors (momentum, volatility) 19
Profitability
23
Margins and returns on capital today
Quality Growth
50
Are margins and returns improving?
Cashflow
71
Earnings quality: real cash, not paper profit
Fin. Strength
67
Balance sheet, leverage, solvency risk
Investment
96
Disciplined investing over empire-building
Low Volatility
46
Calm price path (market factor)
Momentum
12
Price trend over the last 3–12 months (market factor)
52W Momentum
1
Distance to the 52-week high (market factor)
Net Issuance
90
Share count: buybacks or dilution?
Revenue & earnings trend
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.
82/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+15.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.3%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.8%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
−16.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−16.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−31.0% vs −5.2%, slowing
Profit margin 2018 to 2023 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.38% → −15%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
less than -40 %
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
Watch MANOF, get fair value alerts →
Compare Manolete Partners Plc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Context: sector, industry, market
- P/E, EV/EBITDA and margins by industry (reference tables)
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Consulting Services stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| SGS SA SGSN | CHF 94.50 | CHF 70.27 | −26% |
| Verisk Analytics, Inc VRSK | $165.94 | $146.55 | −12% |
| Equifax Inc EFX | $148.11 | $109.78 | −26% |
| Bureau Veritas SA BVI | €26.89 | €27.77 | +3% |
| Booz Allen Hamilton Holding BAH | $69.71 | $158.40 | +127% |
| ALS Limited ALQ | A$20.63 | A$11.20 | −46% |
| DKSH Holding DKSH | CHF 68.90 | CHF 65.52 | −5% |
| FTI Consulting, Inc FCN | $134.29 | $179.80 | +34% |
| Huron Consulting Group HURN | $156.83 | $172.51 | +10% |
| GRG Metrology & Test Group 002967 | ¥17.56 | ¥19.32 | +10% |
Explore undervalued stocks
More undervalued Industrials stocks →
All undervalued stocks
TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
🥇 Backtested Best
🏆 Big Names
⭐ Top Rated
💎 Quality on Sale
🚀 Profitable Growth
🧊 Quality Compounders
💵 Dividend Stars
📈 Strong Momentum
📉 Fallen Angels
⚖️ Deeply Undervalued
🔍 Small-Cap Gems
🏰 Moat at a Fair Price
💼 Insider Buying
🎩 Buffett-Style Quality
📚 Peter Lynch GARP
🧮 Greenblatt Magic Formula
🛡️ Graham Defensive
Discover tools
Stock screenerFilter by region, size and sector
Compare toolTwo stocks side by side
Extrinsic Value Calculator…Calculator with industry benchmark
Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
Frequently asked questions
Is Manolete Partners Plc (MANOF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.6900 versus the last price from Sep 25, 2026 of $0.4942, about +40% upside (undervalued).
What is the fair value of MANOF?
Our model-based fair value for Manolete Partners Plc is $0.6900 (as of Sep 24, 2026), built from audited fundamentals. Last price (from Sep 25, 2026): $0.4942.
What is the quality score of MANOF?
Manolete Partners Plc has a Quality Score of 63/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Manolete Partners Plc (MANOF)?
Our model-based price target is the fair value of $0.6900 (as of Sep 24, 2026) from 23 valuation models. Cautious scenario $0.4800, optimistic scenario $0.8900. It is a calculation from audited fundamentals, not an analyst target.
What is the Manolete Partners Plc stock forecast for 2026?
Our models put fair value at $0.6900, about +40% upside versus the last price from Sep 25, 2026 of $0.4942 (undervalued). Cautious scenario $0.4800, optimistic scenario $0.8900. The calculation is refreshed regularly with new filings.
What is the revenue of Manolete Partners Plc (MANOF)?
Manolete Partners Plc reported trailing-twelve-month revenue of about £28.8M (latest available figure, as of Sep 24, 2026).
What growth is priced into Manolete Partners Plc (MANOF)?
For today's price to be fair in a discounted-cash-flow model, Manolete Partners Plc would have to grow free cash flow by less than minus 40 % per year for five years (discount rate 8.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.3 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of MANOF use?
Our models discount Manolete Partners Plc at 8.8 %: a base by market capitalisation (nano), damped by beta 0.60, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Manolete Partners Plc that is less than minus 40 % per year a year over ten years, using the same discount rate (8.8 %) and the same formula as our fair value.
How much growth has Manolete Partners Plc (MANOF) delivered so far?
Over the past 5 years revenue at Manolete Partners Plc grew +10.3 % a year. The price currently implies less than minus 40 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Manolete Partners Plc (MANOF) growing?
The median revenue growth in the sector is +7.0 % a year. That is the yardstick for the growth priced into Manolete Partners Plc (less than minus 40 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Manolete Partners Plc (MANOF)?
The free-cash-flow yield on the price is 15.19 %: that much free cash flow Manolete Partners Plc produces per unit of market value. When it exceeds the discount rate of our models (8.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Manolete Partners Plc (MANOF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Manolete Partners Plc it is $0.6900 per share (as of Sep 24, 2026), against a price of $0.4942. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Manolete Partners Plc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, MANOF trades below its calculated fair value: price $0.4942, fair value $0.6900, a gap of about +40% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MANOF?
No. The price is what the market pays today ($0.4942); the fair value is what the company's own numbers justify ($0.6900). For Manolete Partners Plc the two are $0.1958 per share apart. That gap is exactly why we show both numbers side by side.
How much is Manolete Partners Plc worth?
The market values Manolete Partners Plc at about $22.0M (market capitalisation, as of Sep 24, 2026). Per share that is $0.4942; our models calculate a fair value of $0.6900 per share.
What do the bullish and bearish scenarios say about MANOF?
Our models span a range for Manolete Partners Plc: cautious scenario $0.4800, base $0.6900, optimistic $0.8900 per share (as of Sep 24, 2026, price $0.4942). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is MANOF from its 52-week high?
Manolete Partners Plc trades at $0.4942, about 60% below its 52-week high of $1.25 and 3% above the low of $0.4800 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.6900 is for.
Which stocks are comparable to Manolete Partners Plc?
From the same area (Industrials) we also value SGS SA, Verisk Analytics, Inc, Equifax Inc, Bureau Veritas SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Manolete Partners Plc stock attractive at the current price?
The data as of Sep 24, 2026: price $0.4942, calculated fair value $0.6900 (+40%), Quality Score 63/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MANOF calculated?
We run Manolete Partners Plc through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.6900, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Manolete Partners Plc currently trades 28 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Manolete Partners Plc (MANOF)?
The latest price we hold is from Sep 25, 2026 and stands at $0.4942. Our model-based fair value is $0.6900, about +40% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Manolete Partners Plc right now?
Solid quality (63/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range ($0.4800 to $0.8900) leaves room in how you read the outcome.
Key figures of Manolete Partners Plc
How large is the market capitalisation of Manolete Partners Plc (MANOF)?
The market capitalisation of Manolete Partners Plc is $22.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of Manolete Partners Plc (MANOF)?
The price-to-earnings ratio of Manolete Partners Plc is 24.7. Price to earnings: how many years of current profit you pay for the stock. A P/E of 10 means ten years of profit.
What is the P/S ratio of Manolete Partners Plc (MANOF)?
The price-to-sales ratio of Manolete Partners Plc is 0.72 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Manolete Partners Plc (MANOF)?
Earnings per share at Manolete Partners Plc are $0.0200 (price ÷ EPS = P/E 24.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Manolete Partners Plc (MANOF)?
The net margin of Manolete Partners Plc is 2.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Manolete Partners Plc (MANOF)?
The return on equity (ROE) of Manolete Partners Plc is 1.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Manolete Partners Plc (MANOF)?
On an EBIT basis the return on assets of Manolete Partners Plc is 4.6% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Manolete Partners Plc (MANOF)?
The operating margin of Manolete Partners Plc is 0.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Manolete Partners Plc (MANOF)?
Revenue at Manolete Partners Plc is growing −11.7% versus a year earlier (3y avg +14.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Manolete Partners Plc (MANOF)?
Earnings per share at Manolete Partners Plc are growing +258% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Manolete Partners Plc (MANOF) carry?
The net debt of Manolete Partners Plc is £11.1M (fiscal year 2025, ≈ 4.4 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Continue in the live analysis
Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check. You can also try 14 days of Pro there, no card.
Open the live analysis →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.